BC Innovations | Feb 19, 2015
Distillery Therapeutics

Therapeutics: Creatine kinase brain (CKB); microRNA-483-5p (miR-483-5p); microRNA-551a (miR-551a)

Cancer INDICATION: Colorectal cancer Mouse studies suggest upregulating miR-483-5p and miR-551a or inhibiting CKB could help treat and prevent liver metastasis in colon cancer. In mouse xenograft models of metastatic colon cancer, overexpression of miR-483-5p...
Items per page:
1 - 1 of 1